The 2019 Medical Affairs
in Rare Diseases Forum

July 22-24, 2019 | Philadelphia, PA

Sheraton Philadelphia University City

Event Overview

The Accreditation Council for Medical Affairs and Dynamic Global Events are excited to announce a partnership that brings a CE/CME-accredited conference experience to medical affairs professionals specializing in rare diseases. 

As advances in genomic and clinical science have created innovative opportunities to design personalized medicine, the pharmaceutical industry must work to reconstruct their business models to combine market opportunities with clinical health benefits. Join us at the Medical Affairs in Rare Diseases Forum to learn from peers and disruptive newcomers about the role Medical Affairs plays in precision medicine.

Featured Session Topics:

  • Analyzing Medical Affairs’ Role in Orphan Drug Development
  • Working with Patient Advocacy Groups: Best Practices
  • What Regulators are Looking for from Medical Affairs in Rare Diseases
  • Skills & Development Training for Medical Affairs Professionals in Rare Diseases
  • Assessing the Orphan Drug Market: What’s Coming Next?
Image

Plus, join us for the Women’s Leadership in Medical Affairs Breakfast on Day One providing the unique opportunity to build your professional network and engage with peers and colleagues.

Sheraton Philadelphia University City

Image

3549 Chestnut St
Philadelphia, PA 19104

(215) 387-8000
Hotel Website

Special Event Rate
Coming Soon

Top Reasons to Attend

  • Earn CME/CE credits at the first-ever accredited event brought to you by the Accreditation Council for Medical Affairs (ACMA) and Dynamic Global Events (DGE)
  • Discover how medical affairs teams are creating advanced strategies and achieving success in rare disease markets
  • Optimize your medical affairs’ ability to understand patient needs and create patient-centric medical information
  • Understand the regulatory pathway and nuances for the orphan drug approval process and the value of natural history studies

Who Will Attend

This conference is designed for executives within life sciences organizations responsible for:

  • Medical Affairs
  • Medical Engagement
  • Product Development
  • Medical Science Liaison
  • Operations

Download the Full Agenda

Tuesday, July 23rd, 2019 | Day 1

 

7:30 AM - 8:00 AM

Registration for Women’s Leadership in Medical Affairs Breakfast 

8:00 AM - 9:30 AM

Women’s Leadership in Medical Affairs Breakfast 

9:00 AM - 9:45 AM

Registration & Continental Breakfast for Main Conference

9:45 AM - 10:00 AM

Chairperson’s Opening Remarks 

10:00 AM - 10:30 AM

Keynote Address: Medical Affairs’ Role in Orphan Drug Development 

Chris Garabedian,  Chairman and CEO
Xontogeny 
Former CEO, Sarepta Therapeutics

10:30 AM - 11:15 AM

Working with Patient Advocacy Groups: Best Practices 

Jodie Sherman Gillon,  Global Medical Lead, Patient Engagement Rare Diseases
Pfizer 

11:15 AM - 11:30 AM

Networking & Refreshment Break

11:30 AM - 12:15 PM

Clinical Trial Design Challenges in Rare Diseases

12:15 PM - 1:15 PM

Networking Lunch

1:15 PM - 2:00 PM

What Regulators Look for from Medical Affairs in Rare Diseases

Melanie Blank,  Medical Officer
Food and Drug Administration  

2:00 PM - 2:45 PM

Set-Up Your Organization for Success: Medical Affairs Departmental Structure in Rare Disease Organizations 

Jaime Arvizu,  Vice President, Head Medical Affairs, LATAM
Ultragenyx  

2:45 PM - 3:00 PM

Networking & Refreshment Break

3:00 PM - 3:45 PM

Maximizing Field Medical Teams in Rare Disease

3:45 PM - 4:30 PM

Effective KOL Engagement in Rare Diseases

4:30 PM - 4:45 PM

Day One Closing Remarks


Wednesday, July 24th, 2019 | Day 2

 

8:00 AM - 9:00 AM

Networking & Breakfast

9:00 AM - 9:15 AM

Chairperson’s Recap of Day One

9:15 AM - 10:00 AM

Medical Affairs Touchpoints Across the Orphan Drug Lifecycle

10:00 AM - 11:15 AM

Fireside Debate: Should HEOR Be Under Medical Affairs or Market Access?

11:15 AM - 11:30 AM

Networking & Refreshment Break

11:30 AM - 12:30 PM

Case Study: Regulatory Pathways to Approval

12:30 PM - 1:30 PM

Networking Lunch

1:30 PM - 2:15 PM

Skills & Development Training for Medical Affairs Professionals in Rare Diseases 

2:15 PM - 2:30 PM

Networking & Refreshment Break

2:30 PM - 3:15 PM

Coordinating US & Global Medical Affairs: Panel Discussion on Best Practices

3:15 PM - 4:00 PM

Assessing the Orphan Drug Market: What’s Coming Next?

4:00 PM - 4:15 PM

Chairperson’s Closing Remarks


Download the Full Agenda

FEATURING

Speakers & Faculty

Nneka Onwudiwe

Nneka Onwudiwe

PRO/PE Regulatory Review Officer
FDA

Tehseen Salim

Tehseen Salim

Head of Medical Affairs – Primary Care and Women’s Health
Merck

Chris Boone

Chris Boone

Vice President, Head of Real World Data and Analytics Center of Excellence
Pfizer

Rosh Dias

Rosh Dias

Former Vice President, Global Scientific Affairs
Amgen

 
Michael Jarjour

Michael Jarjour

Former CEO at Otsuka Digital Health
ACMA Board Member

Robert P. Stevens

Robert P. Stevens

Executive Director & Head, Digital Strategy & Medical Innovation
Novartis

 

REGISTRATION PRICING


CONFERENCE + WORKSHOPS

SUPER EARLY BIRD

Until 4/26/19

$2,196

EARLY BIRD

Until 5/31/19

$2,396

STANDARD

After 5/31/19

$2,596

ON-SITE

Register at Event

$2,796

CONFERENCE ONLY

SUPER EARLY BIRD

Until 4/26/19

$1,496

EARLY BIRD

Until 5/31/19

$1,696

STANDARD

After 5/31/19

$1,896

ON-SITE

Register at Event

$2,096

Register 2 Attendees, Get 1 Complimentary Registration*!

Interested in sending groups of 7 or more? Contact us directly for pricing.

* Standard Pricing Only

THREE DAYS OF EDUCATION AND NETWORKING

DON'T MISS IT

EVENT SPONSORSHIP

Are you a vendor, consultancy, or solutions provider? Our attendees want to hear what you have to offer their organization. We can customize sponsorship packages tailored to your marketing needs.

Please contact Amy Chapman at (561) 571-7687 or achapman@dgevents.com